UOC
ZYNE

UBS O'Connor’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

UBS O'Connor’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-63,614
Closed -$189K – 156
2018
Q4 		$189K Hold
63,614
– – 0.01% 194
2018
Q3 		$519K Buy
+63,614
New +$519K 0.01% 237